Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CELLSCRIPT develops and supplies high-quality enzymes, kits, and reagents to enable the production of functional synthetic RNAs—including modified mRNAs—for use in cell-based research and clinical applications. Their technologies are widely used by academic labs, biotech companies, and pharmaceutical firms developing next-generation RNA therapeutics. The company’s products support both preclinical studies and clinical-stage manufacturing of synthetic RNAs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CELLSCRIPT.